Singapore: A team of scientists from National University of Singapore (NUS) has established novel insights into the rel...
GlaxoSmithKline and biopharmaceutical company, Innoviva, have concluded Salford Lung Study (SLS), a Phase IIIb multi-cen...
Singapore: Singapore has completed phase I clinical trial of an oral-anti-diabetic drug developed by Department of Pharm...
Singapore: New blockbuster cancer drug from South Korea's Hanmi pharmaceuticals is in troubled waters after a patient di...
Singapore: Waters Corporation recently collaborated with Bioprocessing Technology Institute (BTI), a research institute ...
Singapore: Allen David Roses, a renowned neurologist who pioneered breakthrough research in Alzhiemer's Disease, passed ...
Singapore: With a view to speed up the approval process and improve access to breakthrough drugs, the Australian federal...
Munich: Danish Drug maker Novo Nordisk recently announced that patients treated with Semaglutide, an investigational glu...
TOKYO: Eisai Co., Ltd. announced that its European regional headquarters Eisai Europe Ltd. has received license from the...
Singapore: Researchers in Singapore have developed a new protein that can alter DNA in living cells with much higher pre...
Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food & Drug Administrat...
Singapore: Australian company Novogen, engaged in a pilot program aimed at breakthrough development of drugs to treat a ...
Singapore: Glenmark Pharmaceuticals has started the discovery and initiation of IND enabling studies of a novel clinical...
Singapore: Investigational agent, tivozanib, has demonstrated statistically significant and clinically meaningful PFS su...
Pluristem Therapeutics Inc., Israel's developer of placenta-based cell therapy products, has reached an agreement with J...
Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for mus...
Singapore: The US FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support o...
Japanese pharmaceutical giant Chugai Pharmaceutical Co Ltd has announced that its Actemra Subcutaneous Injection (Actemr...
Prosetta Biosciences Inc. has entered into a Feasibility and First Right of Negotiation Agreement with Japan's Takeda Ph...
Pharma Major Lupin announced that its US subsidiary, Gavis Pharmaceuticals LLC., (collectively Lupin) has received final...
Singapore: GlobalData's analysis shows that the global gout therapeutics market grew at a compound annual growth rate (...
Singapore: US-based Repligen has entered into an exclusive worldwide licensing agreement with Pfizer to advance Repligen...
Singapore: United Kingdom (UK) has committed to contrbute $1.6 billion to fight AIDS, Tuberculosis and Malaria. Ms Just...
Singapore: China based biotech firm developing targeted and immune-oncology therapeutics, BeiGene, has raised $75 millio...
Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterpris...
Bangalore: Suven Life Sciences received three product patents one each from Canada (2600271), China (CN 101544592B) and ...
Singapore: US Food and Drug Administration has raised alarm for Gilead Science's cancer medicine Zydelig (idelalisib) du...
Singapore: US-based CytRx, a biopharmaceutical R&D company specializing in oncology, reached an agreement with the U...
Singapore: China based Zai Lab, an innovative biopharmaceutical company, has secured over $100 million in Series B finan...
Singapore: Australian company CSL Behring has submitted a variation application to the European Medicines Agency (EMA) f...
Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreeme...
US-Australian drug discovery company, Novogen Limited has provided an update on progress regarding the development of Ca...
Tokyo: Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunod...
Tokyo: Gordagen Pharmaceuticals, an Australian company developing evidence-based nutraceuticals and pharmaceuticals, has...
Takeda Pharmaceutical Company Limited has announced that the Japanese Ministry of Health, Labour and Welfare has approve...
Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WM...
Singapore: The Systems Toxicology Computational Challenge run under the sbv IMPROVER umbrella, a crowdsourcing initiativ...
A Japanese delegation will initiate a partnership with University of Dundee seeking to develop new treatments for inflam...
Singapore: US Food and Drug Administration has approved Eli Lilly's ramucirumab (Cyramza) for use in combination with Fo...
Singapore: Scientists at A*Star's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IM...
Lung cancer occurs in two types, small cell lung cancer and the more prevalent non-small scale lung cancer. According to...
Singapore: Santaris Pharma, a privately held biopharmaceutical company focused on developing medicines targeted to disea...
Singapore: Japanese company Mitsubishi Tanabe has received approval to manufacture and market the selective DPP-4 inhibi...
Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plan...
Sosei Group Corporation has reported that Heptares Therapeutics, the wholly-owned subsidiary of Japan's Sosei Group Corp...
Singapore: US Food and Drug Administration (FDA) has warned against type 2 diabetes medicine, canagliflozin (Invokana, I...
Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in t...
Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and ...
Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welf...
Singapore: Orient EuroPharma, a specialty pharmaceutical company focused in marketing and commercialization has partnere...
Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that...
Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon sta...
Rock Creek Pharmaceuticals Inc, a clinical-stage drug development company focused on the application of its lead compoun...
Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected wi...
Singapore: Laboratory Corporation of America has released 4th generation HIV antigen/antibody combination assay and a ne...
Japan's pharma giant, Chugai Pharmaceutical Co. has reported that the US Food and Drug Administration (FDA) has granted ...
Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove mali...
Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-fr...
The US subsidiary of Osaka-based Shionogi has announced results of its pivotal phase III study (COMPOSE I). The study re...
Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro d...
Singapore: China based CARsgen Therapeutics, a private and venture backed company focused on the development of CAR-T-ba...
Singapore: Actavis has recieved US Federal Trade Commission (FTC) nod to acquire Forest Laboratories following a propose...
Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new...
Singapore: Kowa Pharmaceuticals and Eli Lilly released results from a pharmacokinetic (PK) study exploring potential dru...
Singapore: Taiwan based TWi Biotechnology has received patent allowance for AC-201, its lead drug candidate, from the Eu...
Tokyo: Japanese regenerative medicine company ReproCELL Inc. has announced the acquisition of the Scottish life science...
Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-e...
Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singa...
Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Tri...
Singapore: Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovat...
Singapore: Sihuan Pharmaceutical Holdings' roxatidine acetate hydrochloride for injection (Roxatidine), which is the com...
Singapore: Geneva based Drugs for Neglected Diseases and Japan's Takeda have collaborated for a Lead Optimization Progra...
Global life sciences company Abbott has announced that the company has observed positive clinical results from ABSORB Ja...
Singapore: Boehringer Ingelheim has achieved positive results from the trial of afatinib in comparison to erlotinib in p...
Singapore: Novartis has partnered with UK based Mereo BioPharma to develop compounds including BPS-804, to improve bone ...
Singapore: India based Jubilant Biosys, subsidiary of Jubilant Life Sciences, and Germany based Sanofi Deutschland have ...
Singapore: Amgen decided to stop the ganitumab (AMG 479) phase III GAMMA (gemcitabine and AMG 479 in metastatic adenocar...
NASDAQ-listed Minerva Neurosciences Inc, a clinical-stage biopharmaceutical company focused on the development of therap...
Singapore: A team comprising Professor Patrick Tan from Duke-NUS Graduate Medical School (Duke-NUS) and A*STAR's Genome ...
Singapore: Clinical trial results on the safety and efficacy of delamanid, Otsuka Pharmaceutical's investigational compo...
Singapore: Recruitment of patients for CAROLINA (cardiovascular outcome study of Linagliptin versus Glimepiride in patie...
Seoul: Boehringer Ingelheim and Eli Lilly & Company have announced new data that reinforces the efficacy and tolerab...
Global biotherapeutics company CSL Behring has submitted its new drug application (NDA) to Japan's Pharmaceuticals and M...
Singapore: Boehringer Ingelheim and Korea's Hanmi Pharmaceutical have collaborated for the development and global commer...
Singapore: New Jersey's Charleston Laboratories Inc and Japanese major Daiichi Sankyo Inc have announced that the US Foo...
Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the cli...
A finding, published in the Latin American Herald Tribune, says that a genetic study of people with Down's syndrome help...
Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021,...
Singapore: Novartis has proceeded to acquire all remaining rights of GSK's Ofatumumab, a fully human monoclonal antibo...
Singapore: Bionomics, a biopharmaceutical company, has filed a patent application for BNC105 in combination with immune ...
Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeu...
Singapore: Novartis has recieved USFDA approval for Promacta (eltrombopag) for the treatment of children six years and o...
Singapore: Agilent Technologies plans to collaborate with the University of Queensland Center for Clinical Research in B...
Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercializati...
Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers...
Singapore: AMRI has acquired all the outstanding shares of Spanish firm, Gadea Pharmaceutical Group, specializing in tec...
Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug pere...
Singapore: SCIEX, a life science analytical technologies provider, and Metabolon, a global company focused on metabolomi...
Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus...
Singapore: European Medicines Agency (EMA) has given a positive indication to Novartis' combination therapy of Tafinlar ...
